Steward Partners Investment Advisory, LLC Dexcom Inc Transaction History

Steward Partners Investment Advisory, LLC

$9.37 Billion
Q2 2024

A detailed history of Steward Partners Investment Advisory, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 63,954 shares of DXCM stock, worth $4.39 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

63,954

Previous 51,737 23.61%

Holding current value

$4.39 Million

Previous $7.18 Million 1.06%

% of portfolio

0.08%

Previous 0.08%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$110.31 - $140.45 $1.35 Million - $1.72 Million	12,217 Added 23.61%	63,954 $7.25 Million
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $5.31 Million - $6.52 Million	46,519 Added 891.51%	51,737 $7.18 Million
Q4 2023 Feb 12, 2024	BUY	$75.49 - $124.16 $173,551 - $285,443	2,299 Added 78.76%	5,218 $647,000
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $1.94 Million - $3.11 Million	-22,561 Reduced 88.54%	2,919 $272,000
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $2.47 Million - $2.88 Million	21,977 Added 627.38%	25,480 $3.27 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $42,016 - $49,659	-404 Reduced 10.34%	3,503 $406,000
Q4 2022 Feb 15, 2023	SELL	$84.98 - $122.67 $41,555 - $59,985	-489 Reduced 11.12%	3,907 $442,000
Q3 2022 Nov 10, 2022	SELL	$76.35 - $94.18 $35,426 - $43,699	-464 Reduced 9.55%	4,396 $354,000
Q2 2022 Aug 04, 2022	BUY	$67.99 - $132.89 $231,845 - $453,154	3,410 Added 235.17%	4,860 $362,000
Q1 2022 May 02, 2022	BUY	$94.08 - $130.2 $846 - $1,171	9 Added 0.62%	1,450 $742,000
Q4 2021 Feb 08, 2022	BUY	$129.87 - $162.82 $30,519 - $38,262	235 Added 19.49%	1,441 $774,000
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $5,015 - $6,729	47 Added 4.06%	1,206 $660,000
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $3,401 - $4,533	42 Added 3.76%	1,159 $495,000
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $72,834 - $89,971	859 Added 332.95%	1,117 $100,000
Q4 2020 Feb 11, 2021	BUY	$78.0 - $104.5 $9,048 - $12,122	116 Added 81.69%	258 $95,000
Q3 2020 Oct 30, 2020	SELL	$95.51 - $112.95 $13,180 - $15,587	-138 Reduced 49.29%	142 $59,000
Q2 2020 Aug 06, 2020	BUY	$62.68 - $105.34 $6,268 - $10,534	100 Added 55.56%	280 $114,000
Q1 2020 Apr 29, 2020	SELL	$47.79 - $75.63 $4,779 - $7,563	-100 Reduced 35.71%	180 $48,000
Q3 2019 Oct 30, 2019	BUY	$35.53 - $43.8 $2,487 - $3,066	70 Added 33.33%	280 $41,000
Q2 2019 Jul 25, 2019	BUY	$27.84 - $38.92 $5,846 - $8,173	210 New	210 $31,000
Q4 2018 Jan 15, 2019	SELL	$26.99 - $37.37 $539 - $747	-20 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$23.35 - $36.72 $467 - $734	20 New	20 $3,000
Q1 2018 Apr 20, 2018	SELL	$13.06 - $18.54 $235 - $333	-18 Closed	0 $0
Q3 2017 Nov 22, 2017	SELL	$11.36 - $18.98 $1,624 - $2,714	-143 Reduced 88.82%	18 $0
Q1 2017 Nov 22, 2017	BUY	N/A	161	161 $13,000

Others Institutions Holding DXCM

# of Institutions

1,057

Shares Held

358M

Call Options Held

4.11M

Put Options Held

3.63M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.

Account

Steward Partners Investment Advisory, LLC Dexcom Inc Transaction History